Ontology highlight
ABSTRACT: Aims
To evaluate the efficacy and tolerability of sitagliptin in subjects with impaired glucose tolerance (IGT).Methods
In a double-blind, parallel-group study, 242 Japanese subjects with IGT, determined by a 75-g oral glucose tolerance test (OGTT) at week -1, were randomized (1 : 1 : 1) to placebo (n = 83), sitagliptin 25 mg (n = 82) or 50 mg (n = 77) once daily for 8 weeks. Glycaemic variables were assessed using another OGTT at week 7 and meal tolerance tests (MTTs) at weeks 0 and 8. Primary and secondary endpoints were percent change from baseline in glucose total area under the curve 0-2 h (AUC(0 -2 h)) during the MTT and OGTT, respectively.Results
Least squares mean percent change from baseline in glucose AUC(0 -2 h) during the MTT were -2.4, -9.5 and -11.5%,
SUBMITTER: Kaku K
PROVIDER: S-EPMC5034821 | biostudies-literature | 2015 Nov
REPOSITORIES: biostudies-literature